| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441430 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
The results do not support previous findings of a link between cyclophosphamide pharmacokinetics or metabolism and disease recurrence in childhood B-cell NHL. While CYP2B6 genotype was shown to influence pharmacokinetics, there was no clear impact on clinical outcome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gareth J. Veal, Michael Cole, Girish Chinnaswamy, Julieann Sludden, David Jamieson, Julie Errington, Ghada Malik, Christopher R. Hill, Thomas Chamberlain, Alan V. Boddy,